Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
OptiNose Community
NasdaqGS:OPTN Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
OptiNose
Popular
Undervalued
Overvalued
Community Investing Ideas
OptiNose
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Improved Prescription Fulfillment And Primary Care Entry Will Unlock Opportunity
Key Takeaways Enhanced sales force execution and improved prescription fulfillment processes are expected to drive revenue growth through better market penetration. Refinement of co-pay assistance and focus on profitable prescriptions could improve net margins and ensure financial sustainability.
View narrative
US$18.00
FV
47.8% undervalued
intrinsic discount
20.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
OPTN
OPTN
OptiNose
Your Fair Value
US$
Current Price
US$9.40
18.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-110m
183m
2015
2018
2021
2024
2025
2027
2030
Revenue US$182.6m
Earnings US$27.3m
Advanced
Set Fair Value